Skip to main content
. 2022 Aug 11;11(3):766–777. doi: 10.1556/2006.2022.00051

Table 1.

Bivariate analyses: baseline characteristics of patients with and without ICBs (N =163)

Total sample (N =163) No ICB (N =106) ICB (N =57) P-value
Mean (sd) or number of patients (%)
Sociodemographic
Age (years) 62.5 (7.8) 63.8 (7.7) 60.2 (7.4) 0.0048
Sex (male) 113 (69.3%) 72 (67.9%) 41 (71.9%) 0.5969
Neurological
MMSE score (/30) 28.5 (1.6) 28.4 (1.7) 28.6 (1.6) 0.4133
Age of PD onset (years) 55.3 (8.0) 56.8 (7.6) 52.5 (8.1) 0.0012
PD duration (years) 10.1 (4.4) 9.8 (4.5) 10.5 (4.1) 0.3715
PD treatment duration (years) 6.9 (4.3) 6.7 (4.6) 7.4 (4.0) 0.3308
Family history of PD (yes) 36 (22.1%) 22 (20.8%) 14 (24.6%) 0.5764
Hoehn and Yahr stage 0.9423
 - 0 3 (1.9%) 2 (1.9%) 1 (1.8%)
 - 1 56 (34.6%) 38 (35.9%) 18 (32.1%)
 - 2 60 (37.0%) 39 (36.8%) 21 (37.5%)
 - ≥ 3 43 (26.5%) 27 (25.5%) 16 (28.57%)
On dopa UPDRS –III (/108) 15.2 (10.7) 15.3 (10.7) 14.9 (11.0) 0.8390
On dopa axial sub-score (/32)* 3.9 (3.8) 3.9 (3.7) 3.98 (4.1) 0.8604
Dyskinesia (presence) 76 (46.6%) 51 (48.1%) 25 (43.9%) 0.6037
Dyskinesia severity 0.8 (0.9) 0.8 (1.0) 0.7 (0.9) 0.8118
Dyskinesia type
 - Chorea 74 (46.0%) 50 (47.6%) 24 (42.9%) 0.5636
 - Dystonia 17 (16.4%) 9 (14.1%) 8 (20.0%) 0.4257
Psychiatric
Family history
 - at least one substance** use disorder 97 (59.5%) 68 (64.2%) 29 (50.9%) 0.0997
 - at least one ICB*** 11 (6.8%) 6 (5.7%) 5 (8.8%) 0.5182
Personal history of substance* use disorder before the PD onset
 - at least one substance use disorder 29 (17.8%) 15 (14.2%) 14 (24.6%) 0.0975
 - nicotine dependence 24 (15.2%) 12 (11.7%) 12 (21.8%) 0.0898
 - alcohol use disorder 8 (5.6%) 3 (3.2%) 5 (10.4%) 0.1198
 - medication use disorder 0 (0%) 0 (0%) 0 (0%)
 - illicit drug use disorder 3 (2.2%) 1 (1.1%) 2 (4.4%) 0.2511
Personal history of ICB*** before the PD onset
 - at least one ICB*** 17 (10.4%) 5 (4.7%) 12 (21.1%) 0.0011
 - compulsive sexual behavior 2 (1.4%) 0 (0%) 2 (4.3%) 0.0994
 - binge eating 9 (5.8%) 2 (1.9%) 7 (13.5%) 0.0070
 - pathological gambling 3 (2.0%) 2 (1.9%) 1 (2.2%) 1.0000
 - compulsive buying 4 (2.7%) 1 (1.0%) 3 (6.3%) 0.0967
 - punding behavior 1 (0.7%) 0 (0%) 1 (2.2%) 0.3129
Personal history of substance* use disorder after the PD onset
 - at least one substance use disorder 10 (6.1%) 5 (4.7%) 5 (8.8%) 0.3214
 - nicotine dependence 7 (4.4%) 4 (3.8%) 3 (5.5%) 0.6925
 - alcohol use disorder 2 (1.3%) 0 (0%) 2 (3.7%) 0.1199
 - medication use disorder 0 (0%) 0 (0%) 0 (0%)
 - illicit drug use disorder 1 (0.7%) 1 (1.0%) 0 (0%) 1.0000
Antisocial personality disorder 0 (0%) 0 (0%) 0 (0%)
Impulsivity dimensions
 - UPPS-Urgency (/48) 25.2 (7.0) 23.6 (5.8) 28.2 (8.1) 0.0003
 - UPPS-(lack of Premeditation) (/48) 17.4 (5.0) 16.9 (4.5) 18.4 (5.7) 0.0848
 - UPPS-(lack of Perseverance) (/48) 16.9 (4.6) 16.5 (4.5) 17.6 (4.8) 0.1609
 - UPPS-Sensations Seeking (/48) 22.1 (7.0) 21.1 (6.6) 24.0 (7.5) 0.0128
ADHD
 - In childhood (WURS-C ≥46/100) 11 (6.8%) 4 (3.8%) 7 (12.3%) 0.0513
 - Persistent in adulthood (WURS-C ≥46/100 AND ASRS ≥4/6) 6 (3.7%) 2 (1.9%) 4 (7.0%) 0.1847

ADHD: attention deficit/hyperactivity disorder; ASRS: adult ADHD self-report scale; ICB: impulsive-compulsive behavior; MMSE: mini-mental state examination; MP: Parkinson's disease; sd: standard deviations; UPDRS: unified Parkinson's disease rating scale; UPPS: UPPS impulsive behavior scale; WURS-C: Wender-Utah Rating Scale-Child.

*: axial sub-score was based on the assessment of speech, facial expression, neck rigidity, arising from chair, gait, postural stability, posture, body bradykinesia; **: “substance” refers to nicotine, alcohol, medication, and illicit drug; ***: “ICB” refers to compulsive sexual behavior, binge eating, pathological gambling, compulsive buying and punding behavior.